Thrombin inhibitors in fibrinolysis - A Hobson's choice of alternatives

被引：17

作者：

Loscalzo, J

机构：

[1] BOSTON UNIV,SCH MED,WHITAKER CARDIOVASC INST,BOSTON,MA 02118

[2] BOSTON UNIV,SCH MED,EVANS DEPT MED,BOSTON,MA 02118

来源：

CIRCULATION | 1996年 / 94卷 / 05期

关键词：

editorials; thrombolysis; thrombosis; coronary disease;

D O I：

10.1161/01.CIR.94.5.863

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：863 / 865

页数：3

共 20 条

[1] HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL [J].

ANTMAN, EM .

CIRCULATION, 1994, 90 (04) :1624-1630

[2] Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial [J].

Antman, EM .

CIRCULATION, 1996, 94 (05) :911-921

[3] TREATMENT WITH BIVALIRUDIN (HIRULOG) AS COMPARED WITH HEPARIN DURING CORONARY ANGIOPLASTY FOR UNSTABLE OR POSTINFARCTION ANGINA [J].

BITTL, JA ;

STRONY, J ;

BRINKER, JA ;

AHMED, WH ;

MECKEL, CR ;

CHAITMAN, BR ;

MARAGANORE, J ;

DEUTSCH, E ;

ADELMAN, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :764-769

[4] A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL [J].

CANNON, CP ;

MCCABE, CH ;

HENRY, TD ;

SCHWEIGER, MJ ;

GIBSON, RS ;

MUELLER, HS ;

BECKER, RC ;

KLEIMAN, NS ;

HAUGLAND, JM ;

ANDERSON, JL ;

SHARAF, BL ;

EDWARDS, SJ ;

ROGERS, WJ ;

WILLIAMS, DO ;

BRAUNWALD, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) :993-1003

[5] ACTIVATION OF PROTHROMBIN ACCOMPANYING THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

EISENBERG, PR ;

SOBEL, BE ;

JAFFE, AS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) :1065-1069

[6] PARADOXIC ELEVATION OF FIBRINOPEPTIDE A AFTER STREPTOKINASE - EVIDENCE FOR CONTINUED THROMBOSIS DESPITE INTENSE FIBRINOLYSIS [J].

EISENBERG, PR ;

SHERMAN, LA ;

JAFFE, AS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (03) :527-529

[7]

GALLISTL S, 1995, THROMB HAEMOSTASIS, V74, P1163

[8] RELATIVE EFFICACY OF ANTITHROMBIN COMPARED WITH ANTIPLATELET AGENTS IN ACCELERATING CORONARY THROMBOLYSIS AND PREVENTING EARLY REOCCLUSION [J].

HASKEL, EJ ;

PRAGER, NA ;

SOBEL, BE ;

ABENDSCHEIN, DR .

CIRCULATION, 1991, 83 (03) :1048-1056

[9] HIRUDIN, HEPARIN, AND PLACEBO DURING DEEP ARTERIAL INJURY IN THE PIG - THE INVIVO ROLE OF THROMBIN IN PLATELET-MEDIATED THROMBOSIS [J].

HERAS, M ;

CHESEBRO, JH ;

WEBSTER, MWI ;

MRUK, JS ;

GRILL, DE ;

PENNY, WJ ;

BOWIE, EJW ;

BADIMON, L ;

FUSTER, V .

CIRCULATION, 1990, 82 (04) :1476-1484

[10] ENDOTHELIAL-CELLS STIMULATED WITH TUMOR-NECROSIS-FACTOR-ALPHA EXPRESS VARYING AMOUNTS OF TISSUE FACTOR RESULTING IN INHOMOGENOUS FIBRIN DEPOSITION IN A NATIVE BLOOD-FLOW SYSTEM - EFFECTS OF THROMBIN INHIBITORS [J].

KIRCHHOFER, D ;

TSCHOPP, TB ;

HADVARY, P ;

BAUMGARTNER, HR .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2073-2083

← 1 2 →